Cleveland Clinic-ko ikertzaileekin lankidetzan egindako argitalpenak (1)

2019

  1. NPM1 mutations define a specific subgroup of MDS and MDS/MPN patients with favorable outcomes with intensive chemotherapy

    Blood Advances, Vol. 3, Núm. 6, pp. 922-933